Polymerase chain reaction with allele-specific oligonucleotides (ASO-PCR) is a technique that can discriminate low levels of the mutant sequence against a background high in wild-type DNA. 14 In ...
In a recent study published in the Journal of Experimental Medicine, researchers identified that individuals with a deficiency of myeloid differentiation primary response 88 (MyD88) and interleukin-1 ...
Brukinsa achieved higher complete or very good partial response rates than Imbruvica in MYD88-mutated Waldenström macroglobulinemia patients. Brukinsa demonstrated faster response times and more ...
"More specifically, we found CYLD inhibits bacteria-induced signaling of MyD88 by deactivating MyD88 at a critical amino acid, lysine 231." CYLD acts as a "brake pedal" during the body's inflammatory ...
Researchers have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Researchers have described ...
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom macroglobulinemia. This is an ASCO Meeting Abstract from the 2012 ASCO ...
Researchers from Wenzhou Medical University and affiliated organizations presented the discovery and preclinical characterization of novel myeloid differentiation primary response 88 (MyD88) inhibitor ...
A phase II evaluation of pemetrexed (ALIMTA, LY231514, IND#40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group No significant ...
This is a preview. Log in through your library . Abstract Toll-like receptors (TLRs)-2 and -4 are important proteins in innate immunity, recognizing microbial products and eliciting host defense ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results